Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Pleural Mesotheliomas (Mpm)”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Not applicableStudy completedNCT00867711
What this trial is testing

Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients

Who this might be right for
MALIGNANT PLEURAL MESOTHELIOMA
Istituto Clinico Humanitas 121
Large-scale testing (Phase 3)Study completedNCT01098266
What this trial is testing

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Who this might be right for
Malignant Pleural Mesothelioma
AGC Biologics S.p.A. 400
Testing effectiveness (Phase 2)Study completedNCT02610140
What this trial is testing

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma
Bayer 248
Testing effectiveness (Phase 2)Study completedNCT02194231
What this trial is testing

ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Malignant Pleural Mesothelioma
Mario Negri Institute for Pharmacological Research 145
Testing effectiveness (Phase 2)Study completedNCT00334594
What this trial is testing

Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
Swiss Cancer Institute 153
Early research (Phase 1)WithdrawnNCT05375825
What this trial is testing

Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

Who this might be right for
Malignant Pleural Mesotheliomas (Mpm)Malignant Pleural Effusions (Mpe)Epithelial Tumors, Malignant+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00700336
What this trial is testing

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)

Who this might be right for
Malignant Pleural MesotheliomaSolid Tumors
CanBas Co. Ltd. 69
Testing effectiveness (Phase 2)Study completedNCT01265433
What this trial is testing

Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy

Who this might be right for
Malignant Pleural Mesothelioma
Sellas Life Sciences Group 41
Testing effectiveness (Phase 2)Study completedNCT05136677
What this trial is testing

Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants

Who this might be right for
Mesothelioma, Malignant
Bristol-Myers Squibb 102
Testing effectiveness (Phase 2)Study completedNCT02716272
What this trial is testing

Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients

Who this might be right for
Mesothelioma
Intergroupe Francophone de Cancerologie Thoracique 125
Testing effectiveness (Phase 2)Ended earlyNCT02863055
What this trial is testing

Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 37
Testing effectiveness (Phase 2)Study completedNCT01112293
What this trial is testing

Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma

Who this might be right for
Pleural Malignant Mesothelioma
Abramson Cancer Center at Penn Medicine 14
Early research (Phase 1)Looking for participantsNCT03760575
What this trial is testing

Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesotheliomas Pleural
Abramson Cancer Center at Penn Medicine 20
Not applicableStudy completedNCT02519049
What this trial is testing

11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma, Malignant
Istituto Clinico Humanitas 30
Testing effectiveness (Phase 2)Study completedNCT02049060
What this trial is testing

Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin

Who this might be right for
Malignant Pleural MesotheliomaNonsquamous Nonsmall Cell Neoplasm of Lung
Armando Santoro, MD 31
Testing effectiveness (Phase 2)Study completedNCT01721018
What this trial is testing

Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.

Who this might be right for
Malignant Pleural Mesothelioma
Virttu Biologics Limited 12
Early research (Phase 1)Ended earlyNCT05228015
What this trial is testing

Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors

Who this might be right for
Solid Tumors, AdultSolid TumorMalignant Pleural Mesothelioma (MPM)+5 more
Ikena Oncology 67
Testing effectiveness (Phase 2)UnknownNCT02497053
What this trial is testing

Four Versus Six Cycles of Pemetrexed/Platinum for MPM

Who this might be right for
Malignant Pleural Mesothelioma
Ain Shams University 70
Testing effectiveness (Phase 2)UnknownNCT00886028
What this trial is testing

Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
National Institute of Cancerología 31
Early research (Phase 1)Study completedNCT00652574
What this trial is testing

Dasatinib in Resectable Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
M.D. Anderson Cancer Center 56
Load More Results